DUBLIN, Aug. 5, 2022 /PRNewswire/ — The “Clinical Chemistry Analyzers: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
This report examines the current and forecast market potential for clinical chemistry analyzers, in terms of product, modality and end user.
By product, the market is segmented into semi-automated and fully automated analyzers. By modality, the market is segmented into benchtop, standalone and handheld/portable. By end user, the market is segmented into hospitals and clinics, diagnostic labs, research institutes and others.
By geography, the market has been segmented into Europe, North America, Asia-Pacific (APAC) and Rest of the World (RoW). Major countries analyzed include the US, Germany, Canadathe UK, Spain, Italy, France, Japan, India and China. For market estimates, data is provided for 2021 as the base year, 2022, and the forecast through year-end 2027.
Estimates are based on manufacturers’ total revenues. Projected and forecast revenue values are in constant US dollars that have not been adjusted for inflation.
Descriptive company profiles of the leading global players, including JEOL Ltd., Abbott Diagnostics Division, Danaher Corp. and Sysmex America inc.
- 29 data tables
- An up-to-date overview and analysis of the global market for clinical chemistry analyzers
- Analyses of the global market trends, with sales data for…